ICRM
BDSI

Insight Capital Research & Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Insight Capital Research & Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-437,059
Closed -$7.47M – 163
2014
Q3 		$7.47M Buy
+437,059
New +$6.34M 1.95% 7

Other funds holding BDSI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Insight Capital Research & Management's BDSI Position: Q4 2014 in Review

Insight Capital Research & Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2014, closing a stake of 437,059 shares — an estimated $7.47M sold.

Insight Capital Research & Management first reported a position in BDSI in Q3 2014 and held it in 1 quarter. The position peaked at $7.47M in Q3 2014. 135 funds tracked by Wall St. Rank hold BDSI as of Q4 2014.

  • Insight Capital Research & Management reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2014 after selling out during the quarter.
  • Insight Capital Research & Management sold 437,059 BioDelivery Sciences International, Inc. shares in Q4 2014, an estimated $7.47M.
  • Insight Capital Research & Management first reported a position in BioDelivery Sciences International, Inc. in Q3 2014 and held it in 1 quarter.
  • Insight Capital Research & Management's BioDelivery Sciences International, Inc. position peaked at $7.47M in Q3 2014.
  • 135 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2014.

Based on Insight Capital Research & Management's 13F filing for Q4 2014, filed 10 Feb 2015.